213 related articles for article (PubMed ID: 33633455)
1. Allergen Immunotherapy: Biomarkers and Clinical Outcome Measures.
Pitsios C
J Asthma Allergy; 2021; 14():141-148. PubMed ID: 33633455
[TBL] [Abstract][Full Text] [Related]
2. Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis.
Živković Z; Djurić-Filipović I; Živanović S
Srp Arh Celok Lek; 2016; 144(5-6):345-50. PubMed ID: 29648760
[TBL] [Abstract][Full Text] [Related]
3. Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
Pfaar O; Gerth van Wijk R
Curr Treat Options Allergy; 2015; 2(1):1-9. PubMed ID: 25798370
[TBL] [Abstract][Full Text] [Related]
4. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.
Pfaar O; Bachert C; Kuna P; Panzner P; Džupinová M; Klimek L; van Nimwegen MJ; Boot JD; Yu D; Opstelten DJE; de Kam PJ
J Allergy Clin Immunol; 2019 Mar; 143(3):970-977. PubMed ID: 30508538
[TBL] [Abstract][Full Text] [Related]
5. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.
Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M
Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570
[TBL] [Abstract][Full Text] [Related]
6. Does evidence support the use of cat allergen immunotherapy?
Dhami S; Agarwal A
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for anti-IgE in combination with specific allergen immunotherapy?
Hamelmann E; Rolinck-Werninghaus C; Wahn U
Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):501-10. PubMed ID: 14612676
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy for treating allergic conjunctivitis.
Calderon MA; Penagos M; Sheikh A; Canonica GW; Durham S
Cochrane Database Syst Rev; 2011 Jul; (7):CD007685. PubMed ID: 21735416
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
10. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
[TBL] [Abstract][Full Text] [Related]
12. Immunologic alterations and efficacy of subcutaneous immunotherapy with Dermatophagoides pteronyssinus in monosensitized and polysensitized patients.
Soyyigit S; Guloglu D; Ikinciogullari A; Secil D; Oztuna D; Mungan D; Misirligil Z; Sin BA
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):244-251.e2. PubMed ID: 26945497
[TBL] [Abstract][Full Text] [Related]
13. Nasal immunotherapy in weed-induced allergic rhinitis.
Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
[TBL] [Abstract][Full Text] [Related]
14. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
15. Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View.
Miraglia Del Giudice M; Licari A; Brambilla I; Tosca MA; Ciprandi G
Children (Basel); 2020 Jun; 7(6):. PubMed ID: 32521598
[TBL] [Abstract][Full Text] [Related]
16. Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitis.
Pfaar O; Klimek L; Gerth van Wijk R
Curr Opin Allergy Clin Immunol; 2015 Jun; 15(3):197-203. PubMed ID: 25899694
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunotherapy for allergic rhinitis.
Wilson DR; Torres LI; Durham SR
Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
Wilson DR; Lima MT; Durham SR
Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
